Form D · Private Equity Fund
G Square Capital CV II L.P.
London, X0 · CIK 0002131654
Offering snapshot reported Jun 15, 2026 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 15, 2026 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06b, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-587320
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Lazard Freres & Co. LLC | 000002528 |
Source: Form D, filed Jun 15, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nazia Ahmed | Executive |
| Renaud Dessertenne | Executive |
| Laurent Ganem | Director |
| N/A G Square Capital (Gp) Cv Ii Llp | Director |
| N/A G Square Healthcare Private Equity Llp | Director |
| Oliver Hoenich | Executive |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
24 Savile Row
London, X0, W1S 2ES
London, X0, W1S 2ES